integrin inhibitors

A biotech with licensing agreements with some of the big-name pharma companies such as AbbVie Inc (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ)'s Janssen unit is testing the IPO waters this week. IPO Terms Waltham, Massachusetts-based Morphic Holding is offering 5 million shares in an IPO...